Another candidate is CD300ld, which was discovered in an in vivo CRISPR-Cas9 screen and was shown to be increased in PMN-MDSCs involved in tumor progression in mouse models, as well as in human tissues from colon and lung cancers [43]. This evidence concerns the gene CD300LD and lung carcinoma.